These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 9795292

  • 1. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ, Muñoz JF, Solís F, Rodríguez FC, Valero A, Casal M.
    Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
    [Abstract] [Full Text] [Related]

  • 2. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
    Carrillo-Muñoz AJ, Quindós G, Gasser I, Tur-Tur C, Ruesga MT, Alonso-Vargas R, Arévalo P, Bornay-Llinares FJ, Santos P, del Valle O.
    Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST, Tanty Haryanty T, Ng KP, Rohani MY, Hamimah H.
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [Abstract] [Full Text] [Related]

  • 4. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S.
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [Abstract] [Full Text] [Related]

  • 5. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
    Lombardi G, Farina C, Andreoni S, Fazii P, Faggi E, Pini G, Manso E, Nanetti A, Mazzoni A.
    Mycoses; 2004 Oct; 47(9-10):397-401. PubMed ID: 15504123
    [Abstract] [Full Text] [Related]

  • 6. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
    Yamane N, Igari J.
    Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
    [Abstract] [Full Text] [Related]

  • 7. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Vivas JR, Torres-Rodríguez JM.
    Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
    [Abstract] [Full Text] [Related]

  • 8. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP.
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [Abstract] [Full Text] [Related]

  • 9. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
    Abdel-Salam HA.
    Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro.
    Dorocka-Bobkowska B, Konopka K.
    Int J Prosthodont; 2007 Sep; 20(5):504-6. PubMed ID: 17944341
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 13. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
    Srimuang S, Prariyachatigul C, Chaiprasert A, Rungsipanuratn W, Tanphaichitra D.
    J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870
    [Abstract] [Full Text] [Related]

  • 14. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW, Johnson EM, Rogers TR.
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P.
    J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E, Parras P, Lozano MC.
    Chemotherapy; 1992 Mar; 38(5):335-9. PubMed ID: 1337508
    [Abstract] [Full Text] [Related]

  • 17. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
    Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):401-5. PubMed ID: 16831406
    [Abstract] [Full Text] [Related]

  • 18. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M, Karaman M.
    Mikrobiyol Bul; 2004 Aug 25; 38(1-2):91-8. PubMed ID: 15293907
    [Abstract] [Full Text] [Related]

  • 19. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
    Alvarado D, Díaz MC, Silva V.
    Rev Med Chil; 2002 Apr 25; 130(4):416-23. PubMed ID: 12090107
    [Abstract] [Full Text] [Related]

  • 20. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S.
    J Antimicrob Chemother; 2004 Feb 25; 53(2):283-9. PubMed ID: 14688039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.